Introducing Oxeltra® Prolonged-Release Tablets

CAN YOU AFFORD TO IGNORE THE SAVINGS?

The NHS spends £28.3m annually on oxycodone hydrochloride modified-release tablets¹

If all oxycodone hydrochloride modified-release tablet scripts area written as the brand Oxeltra® the NHS could save up to £15m annually¹

Adverse event reporting information can be found at the bottom of this page.

PRESCRIBE THE BRAND Oxeltra® PR TABLETS AND SEE THE SAVINGS^2,3

OXELTRA^® PR TABLETS
(OXYCODONE HYDROCHLORIDE)

Why choose between

Fixed Prices
Supply Assurance
and a Quality product

when you can have it all with Oxeltra^®

1 2 3 4 5 6 7 8

*Tablets not shown actual size

FIXED PRICES TO FACILITATE
THE EFFECTIVE LONG TERM FINANCIAL PLANNING

If you currently prescribe Oxeltra® PR tablets then you may already be
making budget savings, but save more by writing all modified-release
oxycodone tablet scripts as the brand Oxeltra®.

Tablet strength / pack size	Drug tariff price ^[2]	Leading branded generic price ^[3]	Oxeltra^® Price	Cost saving vs Drug tariff EVERYTIME
5mg PR tablets (28)	£12.52	£4.69	£3.13	£9.39
10mg PR tablets (56)	£25.04	£9.39	£6.26	£18.78
15mg PR tablets (56)	£38.12	£14.30	£9.53	£28.59
20mg PR tablets (56)	£50.08	£18.78	£12.52	£37.56
30mg PR tablets (56)	£76.23	£28.58	£19.06	£57.17
40mg PR tablets (56)	£100.19	£37.57	£25.05	£75.14
60mg PR tablets (56)	£152.49	£57.18	£38.12	£114.37
80mg PR tablets (56)	£200.39	£75.14	£50.10	£150.29

Savings quoted refer to nic (net ingredient costs) only and do not take into accounts any costs of implementing a switch.

SUPPLY ASSURANCE

In the current climate it’s important more than ever to maintain a consistent supply of medicines to patients, especially for critical, controlled drugs.
Wockhardt UK have an experienced supply team and robust supply chain for all our medicines. We supply over 180 different product lines including many critical medicines that are manufactured both across the world and also from our sterile manufacturing site in the UK.

We currently hold a significant amount of stock of all strengths of Oxeltra® to ensure continuity of supply.
We have a dedicated Product Manager who continuously monitors usage / prescribing trends on each CCG / ICB which allows us to easily anticipate increases in demand and to update the product forecast as and when necessary.
Our in-house Supply Team are working very closely with our supplier who will be briefed if demand was to increase over what has been anticipated. Our priority will always be to ensure continuity of supply for existing patients.

Oxeltra^® is available from all major wholesalers for full national distribution coverage. We have a dedicated Account Manager in each wholesaler who will be briefed to increase stock levels in branches local to new CCGs/ICBs where Oxeltra^® is implemented.

FEATURES OF OXELTRA^®

Oxeltra Prolonged-Release Tablets are licensed⁴:

For the treatment of moderate to severe pain in patients with cancer.

For the treatment of severe pain requiring the use of a strong opioid.

Extensive dose range

Tablets colour-matched to originator brands for patient recognition

12-hourly administration

Biphasic release for immediate and sustained pain relief

Bioequivalent to Oxycontin^®
(summary sheet available on request)

Oxeltra^® tablets are presented in standard blister packs

Click on image to view SmPC/PIL

*Tablets not shown actual size

YOUR COST SAVINGS PARTNER.

Oxeltra® PR tablets are part of Wockhardt UK’s bioequivalent brands portfolio

Helping to maximise Primary Care Budgets
Expanding portfolio in multiple therapy areas
Extended Oxycodone hydrochloride range – also available as an Oral Solution & Solution for injection

Adverse events should be reported. Reporting forms and information can be found at: https://yellowcard.mhra.gov.uk/

Adverse events should also be reported to Wockhardt UK. Please contact us or email us at drug.safety@wockhardt.co.uk

This website has been produced by Wockhardt UK Ltd and is intended for UK based health professionals only
Contact Us | Cookies and Privacy Policy | Terms of and Conditions of Use | PIL | Pharmacovigilance Privacy Notice
Job code: CSB04/25 May 2025

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

CAN YOU AFFORD TO IGNORE THE SAVINGS?

PRESCRIBE THE BRAND Oxeltra® PR TABLETS AND SEE THE SAVINGS2,3

OXELTRA® PR TABLETS(OXYCODONE HYDROCHLORIDE)